Shop created by DDA
Boundless CFX Vaporizer
The Boundless CFX takes aromatherapy innovation to the next level. Featuring 20 seconds or less heat-up time, a full 1.7 inch TFT screen, and rugged exterior casing, the CFX is one of the fastest and efficient portable devices in the industry.
The Boundless CFX has a full range temperature control of 100°F-430°F(37.8°C-221.1°C), fully isolated air path, haptic feedback to alert the user when it is heated, dual charging options, and has a capacity of 2500 mAh with an output voltage of 7.4V. The oven boosts a powerful 80 Watts of power, allowing the device to heat up in 20 seconds or less. Also featured on the screen is a 300 second session timer. After a session is completed, the CFX will go into standby mode until the user holds the power button down for three seconds to start another session
Product Specifications
Weight |
1 lb |
Dimensions |
Length: 120mm x 70mm x 30mm |
Temperature levels |
100°F-430°F • 37.8°C-221.1°C |
Battery Capacity |
(1) Internal 2500 mAh Battery |
Sessions Per Charge |
10-15 sessions |
Chamber Material |
Ceramic chamber |
Heating System |
Hybrid Conduction & Convection |
Additional Features
- Compact and rugged design with textured grooves for comfortable hand placement.
- Built with medical and food grade material.
- Non-combustion aromatherapy device.
- Device vibrates when powered on, when it reaches the desired temperature, and when the device is powered off.
- Dual Charging Options, DC charges unit fully in 30 minutes.
What’s Included?
- CFX Unit
- Cleaning Brush
- Stir Tool
- AC/DC Wall Charger (Please Note: These wall chargers are not for the UK. Product will need charged through the USB Charging Cable provided)
- USB Charging Cable
- Instruction Manual
We at SoCBD do not make any claims as to the medical benefits of our products and any links from our website are not an endorsement of said websites. Our products are sold as dietary supplements.
Our products are not intended to diagnose, treat or cure any illness or disease. These statements have not been evaluated by The Medicines and Healthcare Products Regulatory Agency (MHRA).